Neuroderm is rated 3 out of 5 in the category pharmaceuticals. Read and write reviews about Neuroderm. NeuroDerm is a clinical-stage pharmaceutical company developing next-generation treatments for central nervous system (CNS) disorders that will make a clinically meaningful difference in patients’ lives. NeuroDerm’s technology enables new routes of administration for existing drugs that overcome their current deficiencies and achieve enhanced clinical efficacy.
Company size
51-200 employees